J Med Microbiol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Scott, F. W.
Right arrow Articles by Pitt, T. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scott, F. W.
Right arrow Articles by Pitt, T. L.
Agricola
Right arrow Articles by Scott, F. W.
Right arrow Articles by Pitt, T. L.
J Med Microbiol 53 (2004), 609-615; DOI: 10.1099/jmm.0.45620-0
© 2004 Society for General Microbiology
ISSN 0022-2615

Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales

Fiona W. Scott and Tyrone L. Pitt

Laboratory of HealthCare Associated Infection, Specialist and Reference Microbiology Division, Health Protection Agency, 61 Colindale Avenue, London NW9 5HT, UK

Correspondence Tyrone L. Pitt tyrone.pitt{at}hpa.org.uk

Received January 28, 2004
Accepted March 7, 2004

Most past studies of cross-infection with Pseudomonas aeruginosa among cystic fibrosis (CF) patients in the UK suggest that it is a rare occurrence. However, two recent reports of highly transmissible strains in patients in regional centres in England (Liverpool and Manchester) have raised questions as to the extent of the problem and prompted a nationwide survey to establish the distribution of P. aeruginosa strain genotypes among these patients. Isolates of P. aeruginosa were requested from over 120 hospitals in England and Wales and a sample size of approximately 20 % of the CF patient population in each centre was recommended. In total, 1225 isolates were received from 31 centres (range 1 to 330). Single patient isolates were typed by SpeI macrorestriction and PFGE. A panel of strains of the common genotypes including representatives of reported transmissible strains was assembled and further characterized by fluorescent amplified fragment length polymorphism (FAFLP) genotyping. At least 72 % of all patients harboured strains with unique genotypes. Small clusters of related strains were evident in some centres, presumably indicating limited transmission of local strains. The most prevalent strain was indistinguishable from that previously described as the ‘Liverpool’ genotype, and accounted for approximately 11 % of patient isolates from 15 centres in England and Wales. The second most common genotype (termed Midlands 1) was recovered from 86 patients in nine centres and the third genotype, which matched closely the PFGE profile of Clone C, a genotype originally described in Germany, was found in eight centres and was isolated from 15 patients. A fourth genotype, identical to the published Manchester strain, was found in three centres. FAFLP analysis revealed some microheterogeneity among strains of the Liverpool genotype but all isolates of this genotype were positive by PCR for a strain-specific marker. These data suggest that cross-infection with P. aeruginosa has occurred both within and widely between CF centres in England and Wales. The two most common genotypes accounted for more than one-fifth of patients’ isolates examined and transmissible genotypes were found in all but three centres studied. These results emphasize the need for continued surveillance of P. aeruginosa genotypes in CF patients to provide informed infection control policy in treatment centres.


Abbreviations: CF, cystic fibrosis; FAFLP fluorescent amplified fragment length polymorphism.




This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
C. Etherington, M. Hall, S. Conway, D. Peckham, and M. Denton
Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis
J. Antimicrob. Chemother., February 1, 2008; 61(2): 425 - 427.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
H. Vu-Thien, G. Corbineau, K. Hormigos, B. Fauroux, H. Corvol, A. Clement, G. Vergnaud, and C. Pourcel
Multiple-Locus Variable-Number Tandem-Repeat Analysis for Longitudinal Survey of Sources of Pseudomonas aeruginosa Infection in Cystic Fibrosis Patients
J. Clin. Microbiol., October 1, 2007; 45(10): 3175 - 3183.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
D. T. Kenna, C. J. Doherty, J. Foweraker, L. Macaskill, V. A. Barcus, and J. R. W. Govan
Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis
Microbiology, June 1, 2007; 153(6): 1852 - 1859.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
P. Tingpej, L. Smith, B. Rose, H. Zhu, T. Conibear, K. Al Nassafi, J. Manos, M. Elkins, P. Bye, M. Willcox, et al.
Phenotypic Characterization of Clonal and Nonclonal Pseudomonas aeruginosa Strains Isolated from Lungs of Adults with Cystic Fibrosis
J. Clin. Microbiol., June 1, 2007; 45(6): 1697 - 1704.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Wiehlmann, G. Wagner, N. Cramer, B. Siebert, P. Gudowius, G. Morales, T. Kohler, C. van Delden, C. Weinel, P. Slickers, et al.
Population structure of Pseudomonas aeruginosa
PNAS, May 8, 2007; 104(19): 8101 - 8106.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
L. Jelsbak, H. K. Johansen, A.-L. Frost, R. Thogersen, L. E. Thomsen, O. Ciofu, L. Yang, J. A. J. Haagensen, N. Hoiby, and S. Molin
Molecular Epidemiology and Dynamics of Pseudomonas aeruginosa Populations in Lungs of Cystic Fibrosis Patients
Infect. Immun., May 1, 2007; 75(5): 2214 - 2224.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. Libisch, M. Muzslay, M. Gacs, J. Minarovits, M. Knausz, J. Watine, G. Ternak, E. Kenez, I. Kustos, L. Rokusz, et al.
Molecular Epidemiology of VIM-4 Metallo-{beta}-Lactamase-Producing Pseudomonas sp. Isolates in Hungary
Antimicrob. Agents Chemother., December 1, 2006; 50(12): 4220 - 4223.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
L. Smith, B. Rose, P. Tingpej, H. Zhu, T. Conibear, J. Manos, P. Bye, M. Elkins, M. Willcox, S. Bell, et al.
Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis.
J. Med. Microbiol., December 1, 2006; 55(Pt 12): 1641 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Van daele, M. Vaneechoutte, K. De Boeck, C. Knoop, A. Malfroot, P. Lebecque, J. Leclercq-Foucart, L. Van Schil, K. Desager, and F. De Baets
Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients
Eur. Respir. J., October 1, 2006; 28(4): 740 - 747.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
C. H. M. Smart, F. W. Scott, E. A. Wright, M. J. Walshaw, C. A. Hart, T. L. Pitt, and C. Winstanley
Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1085 - 1091.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
C. H. M. Smart, M. J. Walshaw, C. A. Hart, and C. Winstanley
Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa
J. Med. Microbiol., June 1, 2006; 55(6): 677 - 688.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. M. Jones
Eradication therapy for early Pseudomonas aeruginosa infection in CF: many questions still unanswered
Eur. Respir. J., September 1, 2005; 26(3): 373 - 375.
[Full Text] [PDF]


Home page
J. Bacteriol.Home page
P. Salunkhe, C. H. M. Smart, J. A. W. Morgan, S. Panagea, M. J. Walshaw, C. A. Hart, R. Geffers, B. Tummler, and C. Winstanley
A Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa Displays Enhanced Virulence and Antimicrobial Resistance
J. Bacteriol., July 15, 2005; 187(14): 4908 - 4920.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
D. A. Lewis, A. Jones, J. Parkhill, D. P. Speert, J. R. W. Govan, J. J. LiPuma, S. Lory, A. K. Webb, and E. Mahenthiralingam
Identification of DNA Markers for a Transmissible Pseudomonas aeruginosa Cystic Fibrosis Strain
Am. J. Respir. Cell Mol. Biol., July 1, 2005; 33(1): 56 - 64.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. L. Griffiths, K. Jamsen, J. B. Carlin, K. Grimwood, R. Carzino, P. J. Robinson, J. Massie, and D. S. Armstrong
Effects of Segregation on an Epidemic Pseudomonas aeruginosa Strain in a Cystic Fibrosis Clinic
Am. J. Respir. Crit. Care Med., May 1, 2005; 171(9): 1020 - 1025.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
A. Deplano, O. Denis, L. Poirel, D. Hocquet, C. Nonhoff, B. Byl, P. Nordmann, J. L. Vincent, and M. J. Struelens
Molecular Characterization of an Epidemic Clone of Panantibiotic-Resistant Pseudomonas aeruginosa
J. Clin. Microbiol., March 1, 2005; 43(3): 1198 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. M. Jones, M. E. Dodd, J. R. W. Govan, C. J. Doherty, C. M. Smith, B. J. Isalska, and A. K. Webb
Prospective Surveillance for Pseudomonas aeruginosa Cross-Infection at a Cystic Fibrosis Center
Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 257 - 260.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2004 Society for General Microbiology.